Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients
Angelo Ghezzi, Massimo Filippi(Vita-Salute San Raffaele University), Damiano Baroncini, Gıancarlo Comı(Casa di Cura Columbus), G. Minonzio(Azienda Ospedaliera Sant’Antonio Abate di Gallarate), Pietro Annovazzi(Vita-Salute San Raffaele University), Maria A. Rocca(Vita-Salute San Raffaele University), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla)
Cited by 37
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k